Lazard Asset Management
AUTL

Lazard Asset Management’s Autolus Therapeutics AUTL Stock Holding History

Lazard Asset Management’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-178
Closed – – 2306
2024
Q4 		$0 Hold
178
– – ﹤0.01% 2280
2024
Q3 		$0 Sell
178
-305
-63% -$1.22K ﹤0.01% 2264
2024
Q2 		$1K Sell
483
-6,889
-93% -$29.7K ﹤0.01% 2125
2024
Q1 		$46K Sell
7,372
-4,179
-36% -$26.1K ﹤0.01% 1731
2023
Q4 		$74K Buy
11,551
+531
+5% +$2.02K ﹤0.01% 1771
2023
Q3 		$25K Buy
11,020
+469
+4% +$1.34K ﹤0.01% 2063
2023
Q2 		$24K Buy
10,551
+383
+4% +$909 ﹤0.01% 2065
2023
Q1 		$18K Buy
10,168
+6,416
+171% +$12.5K ﹤0.01% 2065
2022
Q4 		$7K Buy
+3,752
New +$9.49K ﹤0.01% 2227

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return